The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Urokinase Receptor and Fibronectin Regulate the ERKMAPK to p38MAPK Activity Ratios That Determine Carcinoma Cell Proliferation or Dormancy In Vivo
Open accessAbstract
We discovered that a shift between the state of tumorigenicity and dormancy in human carcinoma (HEp3) is attained through regulation of the balance between two classical mitogen-activated protein kinase (MAPK)-signaling pathways, the mitogenic extracellular regulated kinase (ERK) and the apoptotic/growth suppressive stress-activated protein kinase 2 (p38 MAPK), and that urokinase plasminogen activator receptor (uPAR) is an important regulator of these events. This is a novel function for uPAR whereby, when expressed at high level, it enters into frequent, activating interactions with the α5β1-integrin, which facilitates the formation of insoluble fibronectin (FN) fibrils. Activation of α5β1-integrin by uPAR generates persistently high level of active ERK necessary for tumor growth in vivo. Our results show that ERK activation is generated through a convergence of two pathways: a positive signal through uPAR-activated α5β1, which activates ERK, and a signal generated by the presence of FN fibrils that suppresses p38 activity. When fibrils are removed or their assembly is blocked, p38 activity increases. Low uPAR derivatives of HEp3 cells, which are growth arrested (dormant) in vivo, have a high p38/ERK activity ratio, but in spite of a similar level of α5β1-integrin, they do not assemble FN fibrils. However, when p38 activity is inhibited by pharmacological (SB203580) or genetic (dominant negative-p38) approaches, their ERK becomes activated, uPAR is overexpressed, α5β1-integrins are activated, and dormancy is interrupted. Restoration of these properties in dormant cells can be mimicked by a direct re-expression of uPAR through transfection with a uPAR-coding plasmid. We conclude that overexpression of uPAR and its interaction with the integrin are responsible for generating two feedback loops; one increases the ERK activity that feeds back by increasing the expression of uPAR. The second loop, through the presence of FN fibrils, suppresses p38 activity, further increasing ERK activity. Together these results indicate that uPAR and its interaction with the integrin should be considered important targets for induction of tumor dormancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,287
Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7420 · Cited by 2,241
Cyclin D1 Expression Is Regulated Positively by the p42/p44 and Negatively by the p38/HOG Pathway
Lavoie, J. N., L'Allemain, G., Brunet, A., Müller, R., & Pouysségur, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20608 · Cited by 1,211
Werb, Z., Tremble, P. M., Behrendtsen, O., Crowley, E., & Damsky, C. H. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.2.877 · Cited by 1,059
Giancotti, F. G., & Ruoslahtl, E. (1990) · Cell · doi:10.1016/0092-8674(90)90098-y · Cited by 746
Regulation of Integrin Function by the Urokinase Receptor
Wei, Y., Lukashev, M., Simon, D. I., Bodary, S. C., Rosenberg, S., Doyle, M. V., & Chapman, H. A. (1996) · Science · doi:10.1126/science.273.5281.1551 · Cited by 727
Zhong, C., Chrzanowska-Wodnicka, M., Brown, J., Shaub, A., Belkin, A. M., & Burridge, K. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.2.539 · Cited by 605
Ghiso, J. A. A., Kovalski, K., & Ossowski, L. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.89 · Cited by 549
Self-citationEnslen, H., Raingeaud, J., & Davis, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1741 · Cited by 539
Changes in integrin receptors on oncogenically transformed cells
Plantefaber, L. C., & Hynes, R. O. (1989) · Cell · doi:10.1016/0092-8674(89)90902-1 · Cited by 538
Sequestration of GPI-Anchored Proteins in Caveolae Triggered by Cross-Linking
Mayor, S., Rothberg, K. G., & Maxfield, F. R. (1994) · Science · doi:10.1126/science.7516582 · Cited by 510
Wu, C., Keivenst, V. M., O'Toole, T. E., McDonald, J. A., & Ginsberg, M. H. (1995) · Cell · doi:10.1016/0092-8674(95)90184-1 · Cited by 347
Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2
Ben-Levy, R., Hooper, S., Wilson, R., Paterson, H. F., & Marshall, C. J. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70442-7 · Cited by 338
Fibronectin and integrins in invasion and metastasis
Akiyama, S. K., Olden, K., & Yamada, K. M. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00690290 · Cited by 322
Eyers, P. A., Craxton, M., Morricel, N., Cohen, P., & Goedert, M. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90170-3 · Cited by 310
Fibronectin fibrillogenesis: a paradigm for extracellular matrix assembly
Schwarzbauer, J. E., & Sechler, J. L. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00017-4 · Cited by 308
Activation of the Protein Kinase p38 in the Spindle Assembly Checkpoint and Mitotic Arrest
Takenaka, K., Moriguchi, T., & Nishida, E. (1998) · Science · doi:10.1126/science.280.5363.599 · Cited by 261
Adhesion molecules in cancer: the role of integrins
Juliano, R. L., & Varner, J. A. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90030-t · Cited by 261
Toolan, H. W. (1954) · PubMed · Cited by 231
Fibronectin Matrix Regulates Activation of RHO and CDC42 GTPases and Cell Cycle Progression
Bourdoulous, S., Orend, G., MacKenna, D. A., Pasqualini, R., & Ruoslahti, E. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.1.267 · Cited by 230
Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
Teng, D. H. ‐., Perry, W. L., Hogan, J. K., Baumgard, M., Bell, R. N., Berry, S., Davis, T., Frank, D., Frye, C., Hattier, T., et al. (1997) · PubMed · Cited by 193
Molnár, Á., Theodoras, A. M., Zon, L. I., & Kyriakis, J. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13229 · Cited by 190
Aguirre Ghiso, J. A., Alonso, D. F., Farías, E. F., Gomez, D. E., & Bal de Kier Joffè, E. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00507.x · Cited by 185
Self-citationReduction in Surface Urokinase Receptor Forces Malignant Cells into a Protracted State of Dormancy
Yu, W., Kim, J., & Ossowski, L. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.3.767 · Cited by 163
Self-citationOne-way Cross-talk between p38MAPK and p42/44MAPK
Singh, R. P., Dhawan, P., Golden, C., Kapoor, G. S., & Mehta, K. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19593 · Cited by 162
Kusuhara, M., Takahashi, E., Peterson, T. E., Abe, J., Ishida, M., Han, J., Ulevitch, R. J., & Berk, B. C. (1998) · Circulation Research · doi:10.1161/01.res.83.8.824 · Cited by 131
Cheng, H.-L., & Feldman, E. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14560 · Cited by 121
Changes in malignant phenotype of a human carcinoma conditioned by growth environment
Ossowski, L., & Reich, E. (1983) · Cell · doi:10.1016/0092-8674(83)90414-2 · Cited by 102
Self-citationEllinger-Ziegelbauer, H. C., Kelly, K., & Siebenlist, U. K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3857 · Cited by 82
Montero, L., & Nagamine, Y. (1999) · PubMed · Cited by 80
Lengyel, E. R., Wang, H., Gum, R. J., Simon, C., Wang, Y., & Boyd, D. D. (1997) · Oncogene · doi:10.1038/sj.onc.1201098 · Cited by 71
Mortarini, R., Gismondi, A., Santoni, A., Parmiani, G., & Anichini, A. (1992) · PubMed · Cited by 59
Akamatsu, H., Ichihara-Tanaka, K., Ozono, K., Kamiike, W., Matsuda, H., & Sekiguchi, K. (1996) · PubMed · Cited by 55
Saulnier, R., Bhardwaj, B., Klassen, J., Leopold, D., Rahimi, N., Tremblay, E., Mosher, D., & Elliott, B. E. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0045 · Cited by 34
Schiller, J. H., & BITTNER, G. (1995) · PubMed · Cited by 31
Cited by
Molecular principles of metastasis: a hallmark of cancer revisited
Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A., & Fares, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0134-x · Cited by 2,379
Metastatic colonization by circulating tumour cells
Massagué, J., & Obenauf, A. C. (2016) · Nature · doi:10.1038/nature17038 · Cited by 2,062
Models, mechanisms and clinical evidence for cancer dormancy
Aguirre-Ghiso, J. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2256 · Cited by 1,677
Self-citationuPAR: a versatile signalling orchestrator
Blasi, F., & Carmeliet, P. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm977 · Cited by 1,223
Mechanisms of disseminated cancer cell dormancy: an awakening field
Sosa, M. S., Bragado, P., & Aguirre-Ghiso, J. A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3793 · Cited by 1,126
Self-citation
Metadata
- Authors
- Aguirre-Ghiso, J. A., Liu, D., Mignatti, A., Kovalski, K., & Ossowski, L.
- Venue
- Molecular Biology of the Cell
- Published
- 2001-04
- Volume
- 12
- Issue
- 4
- Pages
- 863-879
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- OpenAlex
- W2106263242
- Cited by
- 446
- References
- 35
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.